VEDBAEK, Denmark, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA ...
VEDBAEK, Denmark, Nov. 2, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced that Toumy Guettouche, Ph.D., ...
SAN FRANCISCO, July 14, 2021 /PRNewswire/ -- The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc.
Affymetrix, Inc. (NASDAQ:AFFX) today launched the GeneChip(R) miRNA 2.0 Array. This enhanced version of its best-in-class microRNA (miRNA) interrogation solution will support the research community's ...
San Diego — A liquid biopsy assay that combines a microRNA signature and a well-known biomarker for pancreatic cancer has demonstrated an accuracy of 97% for detecting stage I/II pancreatic ductal ...
Comparison of serum miR-371a-3p assay performance by digital droplet PCR and reverse transcriptase quantitative PCR in patients with malignant germ cell tumor. This is an ASCO Meeting Abstract from ...
This study is led by Professor Jue Ruan (Chinese Academy of Agricultural Sciences, Shenzhen, China). The authors developed a one-pot isothermal detection method based on rolling circle amplification ...
Urinary miRNA-based assay shows high accuracy, potentially transforming pancreatic cancer screening. Study: A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early ...
LAVAL, QUEBEC AND REHOVOT, ISRAEL AND PHILADELPHIA, USA--(Marketwire - Aug. 10, 2009) - Warnex Medical Laboratories, a division of Warnex Inc. , the leading developer of microRNA-based molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback